CSF1R and Cognitive impairment: In contrast, effectively depleting CNS microglia by using PLX5622 (colony-stimulating factor 1 receptor [CSF1R] inhibitor) reduces hippocampal levels of inflammatory mediators and remarkably improves cognitive impairment [16].